Blog

Inventurus Knowledge Solutions IPO (IKS Health IPO) provides services to healthcare enterprises like handling administrative chores/work. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing. Inventurus Knowledge Solutions IPO ( IKS Health IPO) shall be raising Rs 2,497.92 crores. The issue is entirely an offer for sale.

About Inventurus Knowledge Solutions:

• Inventurus Knowledge Solutions (“IKS”) was incorporated on September 5, 2006.
• IKS is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets.
• They are a leading partner for outpatient and inpatient care organizations, enabling healthcare organizations deliver superior clinical care, improve population health outcomes, and transition to the “fee for value” model while optimizing their revenue and reducing operating costs
• The company provides solutions that address these increasing tasks, or ‘chores’, and enable healthcare delivery enterprises to focus on their core focus of healthcare, by taking over chores that are necessary to manage their business. They offer a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care.
• As of September 30, 2024, IKS had 778 healthcare organizations as their clients, including health systems, academic medical centres, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations and other outpatient and inpatient healthcare delivery organizations.

Financials : Inventurus Knowledge Solutions IPO

Anchor: Inventurus Knowledge Solutions IPO

Ahead of its IPO, IKS raised Rs 1,120.18 crore from 61 anchor investors at Rs 1,329 per share. They included Fidelity Funds, Government Pension Fund Global, Abu Dhabi Investment Authority, Prudential Hong Kong, WF Asian Reconnaissance Fund, Destinations International Equity Fund, TIMF Holdings and HSBC Global, among others.

Salient Points:Inventurus Knowledge Solutions (IKS) IPO

• Only 10% retail issue.
• Of the OFS, 35% is by the promoters whose stake will drop from 70% to64% post the IPO. 20% of the IPO is by the senior management.
• The healthcare expenditure in US is expected to grow from US $ 4.8 trillion in 2023 to USD 6.2 trillion by 2028. The addressable market for US enablement technology solutions providers is expected to reach USD 323 bn by 2028, growing at a CAGRof 7.8%.
•  IKS Care Enablement Platform combines innovative technology with human expertise to improve workflows and reduce administrative, clinical, and operational burdens. 

• In Oct 2023,Company acquired peer Aquity Holdings as a strategic acquisition for a consideration of about $ 220 million. Aquity Holdings, was a company engaged in providing technology-enabled clinical documentation, medical coding and revenue integrity solutions for healthcare.
• Through this acquisition, IKS will be able to cross-sell its products to Aquity’s existing customer base of over 804 customers as well as offer solutions offered by Aquity in above three areas to its customers.
• Inventurus Knowledge Solutions had client base of 49 clients, which has grown to 853 clients as a result of this acquisition.
• IKS Health is a trusted partner for 853 clients including the largest hospitals, health systems, and specialty groups across the United States
• They have received many awards and accolades

• In the beginning of Dec 2024, promoters and other shareholders sold 5.2% equity at Rs. 1,329 per share for approximately Rs. 1,200 cr, to institutional investors. This pre IPO placement has reduced IPO size.
• Company operates in the large and fast-growing US healthcare industry, valued at USD 4.8 trillion and growing 8% annually.
• It has exhibited fast financial growthy both organically and inorganically.
• P/E of 54.67 (FY 25 annualized) and based on FY24 earnings, P/E stands at 61.56. 
• I intend to apply in Inventurus Knowledge Solutions IPO. Company has a good focus on the US markets where health care spend is as high as 20% of GDP. IKS looks to be well-positioned to benefit from the increasing digitization of healthcare sector esp. in the U.S. market.
• GMP as reported on social media is around Rs.375 (28%)
• This post is exploratory and educational purposes only.
• Standard disclaimer: I am not a SEBI registered analyst and above analysis is for educational purpose only. Iam a postgraduate in engineering & Management . I have in the past cleared some exams like NISM-Series-V-A: Mutual Fund Distributors Certification, NISM-Series-X-A: Investment Adviser (Level 1) Certification and NISM-Series-X-B: Investment Adviser (Level 2) Examination. This post is my view on the subject matter and is only academic and exploratory in nature. It is not meant to influence investment decisions of investors. I may have bias/vested interest in covered Stock/Mutual Funds/NCD etc. due to my own investment or leaning. Further my understanding of the areas on which I write may be imperfect or incomplete and data could be wrong due to limited time and resources at my disposal. Do check the data from company’s RHP and exchanges before making any decision. Please do your own due diligence as stock market/MF investments have high degree of inherent risk.